✦ LIBER ✦

Meta-analysis of effectiveness and safety of abciximab versus eptifibatide or tirofiban in percutaneous coronary intervention

✍ Scribed by David L Brown; Cathy S.J Fann; Chee Jen Chang

Book ID: 113974510
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 132 KB
Volume: 87
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(00)01427-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of tirofiban, eptifibatide

Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)

✍ Annapoorna S Kini; Merwin Richard; Javed Suleman; Nohelia Perez; Paul Lee; Edwar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Long-term mortality after bolus-only adm

Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention

✍ Jonathan D. Marmur; Shyam Poludasu; Jason Lazar; Erdal Cavusoglu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

TPCT2: COST-EFFECTIVENESS OF ABCIXIMAB I

TPCT2: COST-EFFECTIVENESS OF ABCIXIMAB IN PERCUTANEOUS CORONARY INTERVENTION PATIENTS: RESULTS FROM A META-ANALYSIS

✍ JA Mauskopf; MV Bala; JB Hermiller; BL Barber; KM Anderson 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Time course, magnitude, and consistency

Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention

✍ Dean J Kereiakes; Thomas M Broderick; Eli M Roth; David Whang; Thomas Shimshak; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Comparison of efficacy and safety of nat

Comparison of efficacy and safety of native eptifibatide vs. tirofiban in patients with acute coronary syndrome undergoing percutaneous coronary intervention

✍ Jianjin Tang; Liansheng Wang; Hui Wang; Mingwei Wang; Kejiang Cao; Zhijian Yang 📂 Article 📅 2008 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 132 KB

A comparison of total hospital costs for

A comparison of total hospital costs for percutaneous coronary intervention patients receiving abciximab versus tirofiban

✍ Patrick L. McCollam; Maureen J. Lage; Mohan Bala 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Abstract The purpose of this study was to examine the total hospital costs associated with the receipt of abciximab versus tirofiban for percutaneous coronary intervention (PCI) patients. Hospital billing data for patients with a primary procedure of PCI was examined for the period of July 1998